139 related articles for article (PubMed ID: 9373578)
1. Oral morphine as symptomatic treatment of dyspnoea in patients with advanced cancer.
Boyd KJ; Kelly M
Palliat Med; 1997 Jul; 11(4):277-81. PubMed ID: 9373578
[TBL] [Abstract][Full Text] [Related]
2. Nebulized morphine in the palliation of dyspnoea.
Zeppetella G
Palliat Med; 1997 Jul; 11(4):267-75. PubMed ID: 9373577
[TBL] [Abstract][Full Text] [Related]
3. Dyspnea, relative youth and low daily doses of opioids predict increased opioid dosage in the last week of a terminal cancer patient's life.
Miura T; Matsumoto Y; Motonaga S; Hasuo H; Abe K; Kinoshita H
Jpn J Clin Oncol; 2014 Nov; 44(11):1082-7. PubMed ID: 25249380
[TBL] [Abstract][Full Text] [Related]
4. Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases.
Gamborg H; Riis J; Christrup L; Krantz T
J Opioid Manag; 2013; 9(4):269-74. PubMed ID: 24353020
[TBL] [Abstract][Full Text] [Related]
5. [Dyspnea and morphine aerosols in the palliative care of lung cancer].
Grimbert D; Lubin O; de Monte M; Vecellio None L; Perrier M; Carré P; Lemarié E; Boissinot E; Diot P
Rev Mal Respir; 2004 Dec; 21(6 Pt 1):1091-7. PubMed ID: 15767953
[TBL] [Abstract][Full Text] [Related]
6. Patient-Controlled Therapy of Breathlessness in Palliative Care: A New Therapeutic Concept for Opioid Administration?
Schmitz A; Schulz C; Friebel U; Hohlfeld T; Bausewein C
J Pain Symptom Manage; 2016 Mar; 51(3):581-8. PubMed ID: 26578404
[TBL] [Abstract][Full Text] [Related]
7. [Symptomatic treatment of dyspnoea in patients receiving palliative care: nasal delivery of oxygen compared with opioid administration].
Clemens KE; Klaschik E
Dtsch Med Wochenschr; 2007 Sep; 132(38):1939-43. PubMed ID: 17853348
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of controlled-release oxycodone for dyspnea in cancer patients--three case series].
Shinjo T; Okada M
Gan To Kagaku Ryoho; 2006 Apr; 33(4):529-32. PubMed ID: 16612168
[TBL] [Abstract][Full Text] [Related]
9. The role of benzodiazepines in breathlessness: a single site, open label pilot of sustained release morphine together with clonazepam.
Allcroft P; Margitanovic V; Greene A; Agar MR; Clark K; Abernethy AP; Currow DC
J Palliat Med; 2013 Jul; 16(7):741-4. PubMed ID: 23597092
[TBL] [Abstract][Full Text] [Related]
10. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea.
Abernethy AP; Currow DC; Frith P; Fazekas BS; McHugh A; Bui C
BMJ; 2003 Sep; 327(7414):523-8. PubMed ID: 12958109
[TBL] [Abstract][Full Text] [Related]
11. Continuous Intravenous Morphine Infusion for Severe Dyspnea in Terminally Ill Interstitial Pneumonia Patients.
Takeyasu M; Miyamoto A; Kato D; Takahashi Y; Ogawa K; Murase K; Mochizuki S; Hanada S; Uruga H; Takaya H; Morokawa N; Kishi K
Intern Med; 2016; 55(7):725-9. PubMed ID: 27041155
[TBL] [Abstract][Full Text] [Related]
12. Disabling dyspnoea in patients with advanced disease: lack of effect of nebulized morphine.
Noseda A; Carpiaux JP; Markstein C; Meyvaert A; de Maertelaer V
Eur Respir J; 1997 May; 10(5):1079-83. PubMed ID: 9163650
[TBL] [Abstract][Full Text] [Related]
13. A randomised study comparing the effectiveness of acupuncture or morphine versus the combination for the relief of dyspnoea in patients with advanced non-small cell lung cancer and mesothelioma.
Minchom A; Punwani R; Filshie J; Bhosle J; Nimako K; Myerson J; Gunapala R; Popat S; O'Brien ME
Eur J Cancer; 2016 Jul; 61():102-10. PubMed ID: 27156228
[TBL] [Abstract][Full Text] [Related]
14. Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma.
Tsui BC; Davies D; Desai S; Malherbe S
J Pediatr Hematol Oncol; 2004 Oct; 26(10):678-80. PubMed ID: 15454842
[TBL] [Abstract][Full Text] [Related]
15. Palliation of chronic breathlessness with morphine in patients with fibrotic interstitial lung disease - a randomised placebo-controlled trial.
Kronborg-White S; Andersen CU; Kohberg C; Hilberg O; Bendstrup E
Respir Res; 2020 Jul; 21(1):195. PubMed ID: 32703194
[TBL] [Abstract][Full Text] [Related]
16. Management of refractory breathlessness with morphine in patients with chronic obstructive pulmonary disease.
Smallwood N; Le B; Currow D; Irving L; Philip J
Intern Med J; 2015 Sep; 45(9):898-904. PubMed ID: 26332621
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial on the benefits and respiratory adverse effects of morphine for refractory dyspnea in patients with COPD: Protocol of the MORDYC study.
Verberkt CA; van den Beuken-van Everdingen MH; Franssen FM; Dirksen CD; Schols JM; Wouters EF; Janssen DJ
Contemp Clin Trials; 2016 Mar; 47():228-34. PubMed ID: 26825021
[TBL] [Abstract][Full Text] [Related]
18. Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients.
Clemens KE; Klaschik E
J Pain Symptom Manage; 2007 Apr; 33(4):473-81. PubMed ID: 17397708
[TBL] [Abstract][Full Text] [Related]
19. Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study.
Bruera E; Sala R; Spruyt O; Palmer JL; Zhang T; Willey J
J Pain Symptom Manage; 2005 Jun; 29(6):613-8. PubMed ID: 15963870
[TBL] [Abstract][Full Text] [Related]
20. Blinded Patient Preference for Morphine Compared to Placebo in the Setting of Chronic Refractory Breathlessness--An Exploratory Study.
Ferreira DH; Silva JP; Quinn S; Abernethy AP; Johnson MJ; Oxberry SG; Currow DC
J Pain Symptom Manage; 2016 Feb; 51(2):247-54. PubMed ID: 26598037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
